Absolute Stereochemistry of Amphidinolide E
J . Org. Chem., Vol. 67, No. 5, 2002 1655
mixture was extracted with CHCl3 (100 µL × 3), and then the
organic layer was evaporated in vacuo. The residue was
subjected to C18 HPLC (Develosil ODS-HG-5, Nomura Chemi-
cal Ltd., 10 × 250 mm; eluent CH3CN/H2O, 95:5; flow rate,
2.5 mL/min; UV detection at 311 nm) to afford the 7,8-bis-O-
p-methoxycinnamate (4, 0.03 mg, tR 15 min) and 7,8,17-tris-
O-p-methoxycinnamate (0.02 mg, tR 19 min) of 1. 4 (a colorless
oil): UV (MeOH) λmax 310 (ꢀ 60 000) and 228 nm (sh); 1H NMR
(CDCl3) δ 0.93 (3H, d, J ) 6.6 Hz, H3-28), 1.21 (3H, d, J ) 6.7
Hz, H3-27), 1.20-1.30 (2H, m, H-14 and H-15), 1.42-1.52 (2H,
m, H-14 and H-12), 1.62 (1H, m, H-15), 1.71 (3H, s, H3-30),
1.70-1.78 (2H, m, H-20 and H-12), 1.80 (1H, m, H-11), 2.25-
2.31 (2H, m, H-11 and H-19), 2.41 (1H, brd, J ) 13.7 Hz, H-20),
2.76 (1H, dd, J ) 7.2 and 15.4 Hz, H-24), 2.80 (1H, dd, J ) 6.2
and 15.4 Hz, H-24), 3.27 (1H, m, H-2), 3.47 (1H, m, H-13), 3.60
(1H, dt, J ) 7.5 and 7.0 Hz, H-16), 3.72 (1H, brd, J ) 6.6 Hz,
H-17), 3.81 (6H, s, MeO × 2), 4.68 (1H, d, J ) 9.7 Hz, H-18),
4.71 (1H, brs, H-26), 4.74 (1H, brs, H-26), 4.87 (1H, brs, H-28),
4.98 (1H, brs, H-28), 5.32 (1H, dd, J ) 7.9 and 15.4 Hz, H-9),
5.50-5.60 (3H, m, H-7, H-8, and H-6), 5.66-5.78 (2H, m, H-3
and H-23), 5.82 (1H, ddd, J ) 5.3, 8.3, and 14.7 Hz, H-10),
6.05 (1H, d, J ) 15.6 Hz, H-22), 6.22 (1H, d, J ) 15.9 Hz, H-2′),
6.24 (1H, d, J ) 15.9 Hz, H-2′), 6.24 (1H, dd, J ) 10.8 and
15.1 Hz, H-4), 6.38 (1H, dd, J ) 10.8 and 14.4 Hz, H-5), 6.85
(4H, d, J ) 8.9 Hz, H2-6′ and H2-8′), 7.41 (2H, J ) 8.9 Hz,
H-5′ and H-9′), 7.42 (2H, J ) 8.9 Hz, H-5′ and H-9′), 7.59
(1H, d, J ) 15.9 Hz, H-3′), and 7.60 (1H, d, J ) 15.9 Hz, H-3′);
ESIMS m/z 843 (M + Na)+; HRESIMS m/z 843.4062 [calcd
for C50H60O10Na (M + Na)+, 843.4084].
7,8,17-Tr is-(S)-MTP A E st er (5a ) of Am p h id in olid e E
(1). To a CH2Cl2 solution (20 µL) of amphidinolide E (1, 0.1
mg) were added DMAP (20 µg), triethylamine (1.2 µL), and
(R)-(-)-MTPACl (0.6 µL) at room temperature, and stirring
was continued for 6 h. N,N-Dimethyl-1,3-propanediamine (0.6
µL) was added, and the reaction mixture was stirred for 10
min. After addition of phosphate buffer (pH 6.85, 50 µL), the
reaction mixture was extracted with CHCl3 (100 µL × 3), and
then the organic layer was evaporated in vacuo. The residue
was subjected to C18 HPLC (Develosil ODS-HG-5, 10 × 250
mm; eluent CH3CN/H2O, 95:5; flow rate, 2.5 mL/min; UV
detection at 210 nm) to afford the 7,8,17-tris-(S)-MTPA ester
(5a , 0.12 mg) of 1. 5a (a colorless oil): 1H NMR (CDCl3) δ 0.86
(3H, d, J ) 6.7 Hz, H3-28), 1.25 (3H, d, J ) 6.7 Hz, H3-27),
1.35 (1H, m, H-14), 1.45 (1H, m, H-15), 1.56 (1H, m, H-12),
1.67 (1H, m, H-15), 1.70 (3H, s, H3-30), 1.72 (1H, m, H-12),
1.74 (1H, m, H-20), 1.79 (1H, m, H-14), 1.81 (1H, m, H-19),
2.00 (1H, m, H-11), 2.25 (1H, m, H-20), 2.28 (1H, m, H-11),
2.71 (2H, brt, J ) 7.1 Hz, H2-24), 3.24 (1H, m, H-2), 3.31 (1H,
m, H-13), 3.34 (3H, s, MeO), 3.39 (3H, s, MeO), 3.56 (3H, s,
MeO), 3.64 (1H, dt, J ) 6.7 and 9.3 Hz, H-16), 4.67 (1H, brs,
H-26), 4.72 (1H, brs, H-29), 4.74 (1H, brs, H-26), 4.78 (1H, d,
J ) 10.4 Hz, H-18), 4.93 (1H, brs, H-29), 5.21 (1H, dd, J ) 7.4
and 15.6 Hz, H-9), 5.38 (1H, d, J ) 9.3 Hz, H-17), 5.39 (1H,
dd, J ) 9.3 and 15.3 Hz, H-6), 5.54 (1H, dt, J ) 16.0 and 7.1
Hz, H-23), 5.60 (1H, brt, J ) 9.3 Hz, H-7), 5.65 (1H, m, H-8),
5.67 (1H, m, H-3), 5.75 (1H, dt, J ) 15.6 and 7.1 Hz, H-10),
5.96 (1H, d, J ) 16.0 Hz, H-22), 6.17 (1H, dd, J ) 10.4 and
15.3 Hz, H-4), 6.40 (1H, dd, J ) 10.8 and 15.3 Hz, H-5),
7.31-7.47 (14H, m, Ph), and 7.64 (1H, d, J ) 7.8 Hz, Ph);
ESIMS m/z 1171 (M + Na)+; HRFAB MS m/z 1171.4238 [calcd
for C60H65O12F9Na (M + Na)+, 1171.4230].
brs, H-29), 5.05 (1H, dd, J ) 7.1 and 15.6 Hz, H-9), 5.28 (1H,
dd, J ) 9.3 and 15.3 Hz, H-6), 5.36 (1H, d, J ) 9.3 Hz, H-17),
5.45 (1H, dt, J ) 15.6 and 7.1 Hz, H-10), 5.52 (1H, brt, J )
9.3 Hz, H-7), 5.58 (1H, m, H-8), 5.61 (1H, m, H-23), 5.64 (1H,
m, H-3), 6.03 (1H, d, J ) 15.6 Hz, H-22), 6.15 (1H, dd, J )
10.8 and 15.3 Hz, H-4), 6.35 (1H, dd, J ) 10.4 and 15.3 Hz,
H-5), 7.31-7.47 (14H, m, Ph), and 7.61 (1H, d, J ) 7.8 Hz,
Ph); ESIMS m/z 1171 (M + Na)+; HRFAB MS m/z 1171.4207
[calcd for C60H65O12F9Na (M + Na)+, 1171.4230].
Oxid a tive Degr a d a tion of Am p h id in olid e E (1). To a
solution of 3a , which was prepared from amphidinolide E (1,
0.5 mg) by the same procedure as described above, in THF/1
M phosphate buffer (1:2, 180 µL) was added NaIO4 (1.5 mg),
and the mixture was stirred at room temperature for 1 h. After
addition of phosphate buffer (pH 6.85, 100 µL), the mixture
was extracted with EtOAc (200 µL × 3), and the organic layer
was evaporated in vacuo. To a solution of the residue in EtOH
(75 µL) was added NaBH4 (0.5 mg), and stirring was continued
at 0 °C for 30 min. The mixture was partitioned between
EtOAc (200 µL × 3) and phosphate buffer (100 µL). The organic
phase was evaporated, and the residue was dissolved in 1%
DMAP solution in CH2Cl2 (60 µL). To half of the mixture were
added Et3N (4 µL) and (R)-(-)-MTPACl (2 µL), and stirring
was continued at room temperature for 14 h. After addition
of N,N-dimethyl-1,3-propanediamine (2 µL), the solvent was
evaporated in vacuo. The residue was purified by C18 HPLC
(Develosil ODS-HG-5, 10 × 250 mm; eluent CH3CN/H2O, 95:
5; flow rate, 2.5 mL/min; UV detection at 210 nm) to give 6a
(0.08 mg, tR 22 min) and 7a (0.05 mg, tR 27 min) as colorless
oils. 6b (0.07 mg, tR 23 min) and 7b (0.04 mg, tR 27 min) were
prepared by treatment of the other half of the NaBH4 reduction
product with (S)-(+)-MTPACl, and then HPLC separation was
carried out as described above. 6a (a colorless oil): 1H NMR
(CDCl3) δ 0.90 (3H, d, J ) 6.7 Hz, H3-27), 1.12 (1H, m, H-3),
1.17-1.35 (5H, H-3, H2-4, and H2-5), 1.66 (2H, brt, J ) 6.6
Hz, H2-6), 1.80 (1H, m, H-2), 3.54 (6H, s, MeO), 4.11 (1H, dd,
J ) 5.7 and 10.7 Hz, H-1), 4.16 (1H, dd, J ) 6.5 and 10.7 Hz,
H-1), 4.27 (1H, m, H-7), 4.31(1H, m, H-7), 7.45-7.43 (6H, m,
Ph), and 7.46-7.55 (4H, m, Ph); ESIMS m/z 601 (M + Na)+;
HRESIMS m/z 601.2003 [calcd for C28H32O6F6Na (M + Na)+,
601.2001]. 6b (a colorless oil): 1H NMR (CDCl3) δ 0.88 (3H, d,
J ) 6.7 Hz, H3-27), 1.10 (1H, m, H-3), 1.18-1.33 (5H, m, H-3,
H2-4, and H2-5), 1.65 (2H, brt, J ) 6.9 Hz, H2-6), 1.79 (1H, m,
H-2), 3.52 (6H, s, MeO), 4.04 (1H, dd, J ) 6.5 and 10.7 Hz,
H-3), 4.19 (1H, dd, J ) 5.8 and 10.7 Hz, H-3), 4.25 (1H, dt, J
) 10.9 and 6.6 Hz, H-7), 4.30 (1H, dt, J ) 10.9 and 6.6 Hz,
H-7), 7.33-7.40 (6H, m, Ph), and 7.53-7.57 (4H, m, Ph);
ESIMS m/z 601 (M + Na)+; HRESIMS m/z 601.1991 [calcd
for C28H32O6F6Na (M + Na)+, 601.2001]. 7a (a colorless oil):
1H NMR (C6D6) δ 1.05-1.28 (6H, m), 1.30-1.52 (6H, m), 3.46
(3H, s, MeO), 3.52 (1H, m, H-13), 3.52 (3H, s, MeO), 3.81 (1H,
m, H-16), 3.93 (1H, dd, J ) 1.3 and 11.5 Hz, H-17), 4.01 (1H,
m, H-8), 4.05 (1H, m, H-8), 4.19 (1H, dd, J ) 6.3 and 11.5 Hz,
H-17), 7.05-7.17 (6H, m, Ph), 7.72 (2H, d, J ) 7.7 Hz, Ph),
and 7.78 (2H, d, J ) 7.5 Hz, Ph); ESIMS m/z 643 (M + Na)+;
HRESIMS m/z 643.2103 [calcd for C30H34O7F6Na (M + Na)+,
643.2107]. 7b (a colorless oil): 1H NMR (C6D6) δ 1.05-1.14
(4H, m), 1.18-1.25 (2H, m), 1.38-1.51 (6H, m), 3.46 (3H, s,
MeO), 3.51 (3H, s, MeO), 3.53 (1H, m, H-13), 3.83 (1H, m,
H-16), 4.01 (1H, m, H-8), 4.03-4.08 (2H, m, H-8 and H-17),
4.17 (1H, dd, J ) 3.8 and 11.3 Hz, H-17), 7.05-7.18 (6H, m,
Ph), 7.73 (2H, d, J ) 7.6 Hz, Ph), and 7.77 (2H, d, J ) 7.8 Hz,
Ph); ESIMS m/z 643 (M + Na)+; HRESIMS m/z 643.2120 [calcd
for C30H34O7F6Na (M + Na)+, 643.2107].
7,8,17-Tr is-(R)-MTP A Ester (5b) of Am p h id in olid e E
(1). Amphidinolide E (1, 0.1 mg) was treated with (S)-(+)-
MTPACl (0.6 µL) by the same procedure as described above
to afford the bis-(R)-MTPA ester (5b, 0.15 mg) of 1. 5b
(colorless oil): 1H NMR (CDCl3) δ 0.90 (3H, d, J ) 6.7 Hz,
H3-28), 1.29 (3H, d, J ) 6.7 Hz, H3-27), 1.29 (1H, m, H-14),
1.41 (2H, m, H-12 and H-15), 1.58 (1H, m, H-12), 1.63 (1H, m,
H-15), 1.69 (3H, s, H3-30), 1.71 (1H, m, H-14), 1.80 (1H, dd, J
) 10.4 and 13.8 Hz, H-20), 1.82 (1H, m, H-11), 2.00 (1H, m,
H-19), 2.09 (1H, m, H-11), 2.33 (1H, dd, J ) 3.4 and 13.4 Hz,
H-20), 2.72 (2H, m, H2-24), 3.17 (1H, m, H-13), 3.26 (1H, m,
H-2), 3.43 (3H, s, MeO), 3.46 (3H, MeO), 3.46 (1H, m, H-16),
3.53 (3H, s, MeO), 4.67 (1H, brs, H-26), 4.73 (1H, brs, H-26),
4.81 (1H, d, J ) 10.4 Hz, H-18), 4.82 (1H, s, H-29), 4.99 (1H,
2-[(2′S,5′R)-5′-Ben zyloxym eth yltetr a h yd r ofu r a n -2′-yl]-
eth a n -1-ol (9). To a suspension of NaH (283 mg, 7.08 mmol,
60% oil dispersion) in DMF (1.6 mL) and THF (2.7 mL) was
added a solution of (2R,5S)-{5-[2′-(tert-butyldimethylsilyloxy)-
ethyl]tetrahydrofuran-2-yl}methanol (8, 1.00 g, 3.84 mmol) in
THF (0.7 mL) at 0 °C. After stirring at 0 °C for 30 min and
then at room temperature for 2 h, benzyl bromide (0.6 mL,
5.1 mmol) was added at 0 °C, and the mixture was stirred at
room temperature for 18 h. After addition of MeOH (0.4 mL)
and then H2O (11 mL), the mixture was extracted with ether
(20 mL × 3). The organic phase was dried with MgSO4 and